Innate Pharma S.A. (EPA: IPH)
France
· Delayed Price · Currency is EUR
1.732
0.00 (0.00%)
Jan 20, 2025, 10:08 AM CET
Innate Pharma Employees
Innate Pharma had 179 employees as of December 31, 2023. The number of employees decreased by 32 or -15.17% compared to the previous year.
Employees
179
Change (1Y)
-32
Growth (1Y)
-15.17%
Revenue / Employee
€201,119
Profits / Employee
€202,690
Market Cap
144.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sanofi | 86,088 |
EssilorLuxottica Société anonyme | 151,292 |
Sartorius Stedim Biotech | 10,662 |
bioMérieux | 13,982 |
Ipsen | 5,325 |
Eurofins Scientific SE | 61,798 |
Virbac | 5,459 |
Ramsay Générale de Santé | 34,218 |
Innate Pharma News
- 11 days ago - Innate Pharma Announces Transformative Strategy to Accelerate Growth - Business Wire
- 4 weeks ago - Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 6 weeks ago - Innate Pharma presents lacutamab improved health-related quality of life data at ASH 2024 - Seeking Alpha
- 6 weeks ago - Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma - Business Wire
- 6 weeks ago - Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma - Business Wire
- 7 weeks ago - Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024 - Business Wire
- 2 months ago - Innate Pharma: Looking Like A Company We'll Regret Ignoring - Seeking Alpha
- 2 months ago - Innate Pharma Releases Its 2025 Financial Calendar - Business Wire